Status:
COMPLETED
Test Serum Clinical Study
Lead Sponsor:
ChinaNorm
Conditions:
Redness
Eligibility:
FEMALE
25-40 years
Phase:
NA
Brief Summary
This 4-week, mono-centric clinical study employed a randomized three-arm design to evaluate the efficacy of a test serum. The study compared three interventions: the test serum used alone, the test se...
Eligibility Criteria
Inclusion
- Chinese female with 25-40 years old.
- All skin types by subjects' self-perceived.
- Willing to perform HA injection.
- Did not perform any of the beauty procedure projects in the past 6 months.
- Lack of hydration, radiance, brightness, smoothness, firmness and elasticity by self-claimed.
- Presenting with corresponding severity for the attribute evaluated by Dermatologist included:
- Radiance, smoothness, elasticity, cheek plumpness and firmness: 3≤grade≤6.
- Global fine lines: 3≤grade.
- Underneath eye wrinkles: 2≤grade≤5.
- Forehead wrinkles: 1\<grade≤4.
- Glabella wrinkles: 1\<grade.
- All accept not to use any cosmetics, skincare products, beauty equipment, all topical medications and cleansing products on face at visit days.
- Did not participate any clinical test or cosmetic product test on skin within 1 months.
- No disagreement of dermatologist because of other reasons that exclude the participation of the volunteer.
- In general, good health at the time of the study.
- Willing and able to participate as evidenced by signing of informed consent \& photo release form.
- Must be willing to comply with all study protocol requirements.
Exclusion
- Pregnant or breast-feeding woman or woman planning pregnancy during the study.
- Subject deprived of rights by a court or administrative order.
- Major subject to a guardianship order.
- Subject residing in a health or social care establishment.
- Patient in an emergency setting.
- Subject with a skin disease in the test areas as well as skin allergy (particularly e.g., acne, rosacea, eczema).
- Subject presenting a stable or progressive serious disease (per investigator's assessment).
- Immuno-compromised subject.
- Subject with history of allergy to cosmetic or personal care products or ingredients.
- Subject presenting excessive exposure to sunlight or UV radiation (investigator's assessment).
- Subject with history of sunlight sensitivity or allergies.
- Subject regularly practicing aquatic or nautical sports.
- Subject regularly attending a sauna.
- Subject with physical highly sensitive constitution.
- Subject with cardiovascular or circulatory history.
- Subject with a history of skin cancer or malignant melanoma.
- Intake of antihistamines, antibiotics, corticosteroids, non-steroidal anti-inflammatories or immune-suppressants in the last 6 months before study.
Key Trial Info
Start Date :
June 23 2025
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 9 2025
Estimated Enrollment :
90 Patients enrolled
Trial Details
Trial ID
NCT07200635
Start Date
June 23 2025
End Date
September 9 2025
Last Update
November 17 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Shanghai China-norm Quality Technical Service Co., Ltd.
Shanghai, Shanghai Municipality, China, 200072